Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -88.07M
March 31, 2026 -95.45M
December 31, 2025 -104.72M
September 30, 2025 -113.16M
June 30, 2025 -114.91M
March 31, 2025 -114.60M
December 31, 2024 -110.29M
September 30, 2024 -113.12M
June 30, 2024 -102.51M
March 31, 2024 -98.66M
December 31, 2023 -102.30M
September 30, 2023 -104.40M
Date Value
June 30, 2023 -121.66M
March 31, 2023 -134.04M
December 31, 2022 -17.05M
September 30, 2022 -28.95M
June 30, 2022 -34.62M
March 31, 2022 -28.13M
December 31, 2021 -134.76M
September 30, 2021 -110.19M
June 30, 2021 -84.07M
March 31, 2021 -65.57M
December 31, 2020 -51.09M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Tenax Therapeutics, Inc. -46.03M
Exicure, Inc. -6.385M
Absci Corp. -108.97M
Celularity, Inc. -8.814M
Cardio Diagnostics Holdings, Inc. -6.106M